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Abstract
Introduction: Primary myofibroblastic sarcoma of the bone is a rare spindle cell tumour with, to the best of our 
knowledge, only eight cases reported in the available English language literature. The disease's rarity and its low-grade 
features make an accurate diagnosis difficult in most cases. The differential diagnoses of this unusual tumour include 
various benign entities as well as other sarcomas. Due to the difference in prognosis, a precise pathologic diagnosis is 
essential, which requires a combination of thorough morphologic examination, immunohistochemistry and electron 
microscopy wherever available.
Case presentation: We report the case of a 38-year-old Indian woman with a lytic lesion in her left femur. The tumour 
was associated with cortical destruction and soft tissue extension. A biopsy from the soft tissue component showed 
features suggestive of a low-grade malignant mesenchymal tumour. Excision of the tumour was performed and 
histopathological examination showed a low-grade spindle cell sarcoma with collagenous stroma. Expressions of 
vimentin and smooth muscle actin were also noted. Ultrastructural examination confirmed its myofibroblastic nature. 
A final diagnosis of low-grade myofibroblastic sarcoma of the left femur was thus rendered.
Conclusion: Low-grade myofibroblastic sarcoma is one of the rarer osseous spindle cell sarcomas depicting a 
favourable prognosis in the cases reported so far. Its diagnosis requires ancillary techniques like immunohistochemistry 
and electron microscopy. To the best of our knowledge, we report the ninth case in the literature and the first case 
from our subcontinent.
Introduction
Myofibroblasts are mesenchymal cells showing charac-
teristics of both fibroblasts and smooth muscle cells. In
addition to its role in wound healing, they have been
described in soft tissue tumours like myofibroblastoma,
angiomyofibroblastoma, myofibromatosis and inflamma-
tory myofibroblastic tumour [1,2]. Myofibroblastic sar-
coma was characterized as a distinct neoplasm in 1998 by
Mentzel et al. [3]. Primary myofibroblastic sarcoma of the
bone is rare with only eight cases reported in the available
English language literature [3-8]. To the best of our
knowledge, no such case has been reported from our sub-
continent.
The histopathological differential diagnoses of this rare
neoplasm include benign myofibroblastic proliferations
and sarcomas such as well-differentiated intraosseous
osteosarcoma, leiomyosarcoma, fibrosarcoma and malig-
nant fibrous histiocytoma of the bone [9-11]. An accurate
diagnosis is essential since low-grade myofibroblastic sar-
coma has a favourable prognosis compared to other
osseous sarcomas. This requires the use of ancillary tech-
niques like immunohistochemistry.
We describe a case of low-grade myofibroblastic sar-
coma occurring in the femur of a 38-year-old woman.
This rare entity is briefly reviewed with a discussion of
various differential diagnoses.
Case presentation
A 38-year-old Indian woman presented in our hospital
with a two-year history of swelling and pain in her left
thigh and hip. The swelling was progressive in nature. She
had no history of trauma prior to the swelling. No signifi-
cant personal or family history was present. On examina-
tion, there was a 20 × 10 cm soft tissue swelling involving
the anterolateral aspect of her left thigh and extending to
her hip. There was mild tenderness over the swelling and
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Page 2 of 5movements at her hip joint were painfully restricted.
Results of systemic examination, however, were unre-
markable.
Routine haematological and biochemical investiga-
tions, including alkaline phosphatase, were within refer-
ence ranges. Radiological investigations, such as
computed tomography (CT) scan and magnetic reso-
nance imaging (MRI), revealed a diffuse, irregular, ill-
defined heterogeneous altered marrow signals in our
patient's left upper femoral metaphysis and extending
into the epiphysis and diaphysis. The altered marrow sig-
nals were seen to extend up to the lower shaft diaphysis
and metaphysis. Similar signals were also noted in her left
pelvic bone (acetabulum and pubic). There was anterior
and posterior cortical disruption in her upper femoral
metaphysic with extension into the adjacent soft tissues.
The altered marrow signals were hyperintense on T2-
weighted and short inversion recovery (STIR) images. On
the other hand, the signals were low on T1-weighted
images (Figure 1).
A bone scan confirmed these findings. No other skele-
tal lesions were likewise detected. The radiological fea-
tures were suggestive of a malignant neoplasm. A core
biopsy from the soft tissue swelling, which was per-
formed at another hospital, was reviewed at our institute
and showed a spindle cell tumour with focal nuclear pleo-
morphism, intercellular collagenous stroma, and occa-
sional mitotic figures. With an initial diagnosis of
malignant mesenchymal tumour, our patient underwent
proximal femoral resection and prosthesis reconstruc-
tion.
We received our patient's proximal femur measuring 13
× 9 × 7 cm with a fusiform swelling, with 8 × 7 × 4 cm of
the femur involving metaphysis. The tumour was seen to
destroy the cortex and was extending into the soft tissue
(Figure 2). Multiple sections from the tumour showed a
spindle cell lesion composed of hypercellular fascicular
and hypocellular fibrous areas (Figure 3A). The hypercel-
lular foci showed spindle cells arranged in short fascicles
and focally in a storiform pattern. The spindle cells had
abundant eosinophilic cytoplasm and elongated nuclei. It
also had finely dispersed chromatin and inconspicuous
nucleoli. There was moderate nuclear pleomorphism and
some nuclei showed indented nuclear membranes (Figure
3B and 3C). Occasional bizarre nuclei and a mitotic count
of 1 to 2 per 10 high power fields (HPF) were also seen
(Figure 3D). There was no osteoid deposition, necrosis,
or multinucleated giant cells in the numerous sections
studied.
The spindle cells were found to be positive for vimentin
and smooth muscle actin and negative for desmin, S-100
protein, myogenin and CD68 on immunohistochemistry.
MIB-1 labeling index was low at 1% to 2%. Ultrastructural
examination showed spindle-shaped cells with abundant
rough endoplasmic reticulum, scattered mitochondria,
Figure 1 Magnetic resonance imaging shows evidence of lobulated soft tissue mass involving the upper end of left femur. (A) The mass was 
hypointense on T1-weighted imaging and (B) hyperintense on short inversion recovery imaging.
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suggestive of a myofibroblastic nature (Figure 4).
The histomorphological, immunohistochemical and
ultrastructural features suggested a final diagnosis of low-
grade myofibroblastic sarcoma of the left upper femur.
Our patient is currently on follow-up with no appreciable
increase in the residual tumour.
Discussion
Myofibroblasts have been characterized in the last three
decades, as mesenchymal spindle cells sharing features of
both fibroblasts and smooth muscle cells. These cells
have been shown to play an important role in wound
healing [4]. In addition, myofibroblasts have been recog-
nized in pseudosarcomatous proliferations, hypertrophic
scars, and superficial and deep fibromatoses [3]. Over the
last few years, neoplasms including infantile digital fibro-
matosis, myofibromatosis, mammary myofibroblastoma,
dermatomyofibroma, cutaneous myofibroma and angio-
myofibroblastoma have been described as composed pri-
marily of myofibroblasts [1]. In 1998, Mentzel et al.
characterized myofibrosarcoma or myofibroblastic sar-
coma as a spindle cell sarcoma composed of myofibro-
blasts. In their study, they showed that the myofibroblasts
stained positively for at least one of the myogenic mark-
ers (desmin, smooth muscle actin, and smooth muscle
myosin heavy chain) and vimentin [3].
Histopathologically, myofibroblastic sarcomas (MFS)
are composed of slender spindle cells with variable
nuclear pleomorphism and mitotic activity. The spindle
cells are arranged in interlacing fascicles and have eosino-
philic cytoplasm, which may be occasionally wavy. In
addition, collagenous stroma is also seen [2,6,12]. Low-
grade MFS (LGMFS) lacks necrosis and prominent
nuclear pleomorphism, as seen in our patient [3].
Primary MFS of the bone is an extremely rare neo-
plasm. An extensive literature search yielded only eight
previously reported cases of osseous MFS [3-8]. Of the
reported cases, the most common location was the femur,
followed by the iliac bone. The tumours have occurred
over a wide age range with no gender predilection. Mean-
while, therapeutic approaches in these cases have varied
from simple curettage to amputation with some patients
receiving radiotherapy. Of the eight patients reported, six
have done well without local recurrence or distant metas-
tasis in follow-up periods ranging from 2 to 16 years.
Figure 4 Electron photomicrograph showing a tumour cell with 
prominent endoplasmic reticulum and surrounded by collagen 
fibrils (Uranyl acetate and Lead citrate ×13,000).
Figure 2 Gross specimen of the proximal femur showing a grey-
white firm tumuor (asterisk) with destruction of the adjacent cor-
tex.
Figure 3 (A) Photomicrographs demonstrating a spindle cell tu-
mour with interspersed hypocellular areas (Hematoxylin and Eo-
sin stain, ×40 magnificaiton). (B) The spindle cells show moderate 
degree of nuclear pleomorphism (Hematoxylin and Eosin stain, ×100 
magnification). (C) Occasional bizarre tumour cells (Hematoxylin and 
Eosin stain, ×200 magnificaiton). (D) An occasional mitotic figure was 
noted (Hematoxylin and Eosin stain, ×400 magnificaiton).
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tumour and a 49-year-old man with tumour in the right
maxilla) died with distant metastasis. These two patients
showed a high mitotic count (6 to 8 per 10 HPF) and
necrosis. However, these histopathological features did
not correlate well with prognosis, since some cases with
high mitotic activity and marked atypia pursued an indo-
lent course. Both patients who died of their disease were
treated by wide resection with radiotherapy and/or che-
motherapy. Due to the unpredictable behaviour of their
disease, these patients had to be kept under close follow-
up, especially because the histopathological features of
the disease do not seem to predict accurately its biologic
behaviour. The reported cases of osseous MFS are sum-
marised in Table 1.
MFS needs to be differentiated from tumours like con-
ventional osteosarcomas, chondroblastoma and solitary
fibrous tumour, which may show focal or extensive myoid
differentiation. These tumours can be differentiated by
their clinicopathological features [11]. Another tumour,
well-differentiated intraosseous osteosarcoma, may be
confused with MFS since the former may be composed
predominantly of fibrous tissues [9]. Well-differentiated
osteosarcoma occurs in adolescents and young adults as a
bone-forming tumour (evident on radiology and histol-
ogy) with less cellular atypia than MFS.
Other neoplasms that enter the list of differential diag-
noses include leiomyosarcoma, fibrosarcoma, and malig-
nant fibrous histiocytoma of the bone. Leiomyosarcoma,
whether primary or metastatic, can be differentiated by
its lack of prominent collagenous stroma and expression
of h-caldesmon [11]. Fibrosarcoma of the bone has mor-
phological similarities to LGMFS. These include wavy
spindled cytoplasm, collagenous stroma, and wide spec-
trum of cellular anaplasia. However, LGMFS can be dis-
tinguished by the immunohistochemical expression of
myoid antigens [2]. Unlike LGMFS, on the other hand,
malignant fibrous histiocytoma (MFH) shows marked
cellular anaplasia with multinucleated giant cells [10].
Conclusion
Low-grade myofibroblastic sarcoma is an unusual
osseous neoplasm. It needs to be differentiated from
other spindle cell tumours of the bone using immunohis-
tochemical expression pattern and/or electron micros-
copy. A close radiological and pathological correlation is
mandatory to exclude other entities and to make an accu-
rate diagnosis. The biologic behaviour of this rare neo-
plasm is difficult to predict because only a few cases have
been reported so far. Reports of more cases in the litera-
ture would help clinicians define this entity better.
Table 1: Summary of reported cases of myofibroblastic sarcoma of the bone.





Majno G[5] 1 49/M Jaw 8 cm WR + RT DOD
Bisceglia et al.[2] 1 24/M Jaw 4 cm WR AWOD
Montgomery et al.[8] 1 65/M Tibia 6 cm WR + Amp AWOD
Watanabe et al.[11] 4 60/M Femur 5 cm WR + CT AWOD
63/W Femur 9 cm Curettage AWOD
66/W Ilium 9.5 cm WR + CT AWOD
71/W Ilium 7 cm WR + CT DOD
San Miguel et al.[9] 1 51/W Distal 
phalanx
1.8 cm Local 
excision
AWOD
Present case 1 38/W Femur 8 cm Resection AED
M, man; W, woman; WR, wide resection; CT, chemotherapy; Amp, amputation; RT, radiotherapy; DOD, dead of disease; AWOD, alive without 
disease; AED, alive with evidence of disease.
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